MBTPS1 and breast cancer: Moreover, in these papers, the authors have also extensively discussed the preclinical studies carried out in both ER+ and TNBC mouse models with inhibitors of SphK1 and other compounds that target the S1P axis, suggesting them as a good promise for reducing BC growth and metastasis.